The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,956.00
Bid: 4,968.00
Ask: 4,970.00
Change: 38.00 (0.77%)
Spread: 2.00 (0.04%)
Open: 4,934.00
High: 5,015.00
Low: 4,916.00
Prev. Close: 4,918.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

3 Aug 2018 07:00

RNS Number : 7100W
Intertek Group PLC
03 August 2018
 

 

3 August 2018, 7.00 am London, UK

 

 

Intertek expands its global Assurance business with the acquisition of Alchemy,

a leading provider of SaaS-based People Assurance solutions

Transaction highlights

- Industry-leading People Assurance content and technology platforms

- Attractive business model: high growth, high margin, strongly cash-generative, capital light and scalable

- Strong management team joining Intertek

- Transaction consideration: US$480m financed using available debt facilities and cash

- 2018e Billings of US$66m and 2018e adjusted billings basis EBITDA of US$22m

- Expected to be EPS accretive on a billings basis from the first full year

- 5 Year guidance:

§ 20% growth p.a. in billings/revenues going forward

§ >30% IFRS EBITDA margin by year 5

§ Strong cash conversion / negative working capital

§ ROIC > Group WACC by year 5

 

 

Intertek Group plc ("Intertek" and the "Group"), a Total Quality Assurance provider to a range of industries worldwide, is pleased to announce that it has entered into an agreement to acquire Alchemy Investment Holdings, Inc. ("Alchemy"), an industry leader in People Assurance solutions for the food industry.

 

In a world of increasingly complex supply chains and distribution channels, employees are key in driving operational excellence in multi-site organisations and there is a growing demand for bespoke People Assurance solutions to identify/monitor and efficiently close critical skills gaps amongst frontline employees.

 

Intertek is a global market leader in Assurance solutions, enabling clients to identify and mitigate the intrinsic risk in their operations, supply and distribution chains and quality management systems. The acquisition of Alchemy, a high-growth, high-margin, highly cash-generative, capital-light technology-enabled People Assurance solutions provider, will further strengthen Intertek's global Assurance offering.

 

Alchemy has developed industry-leading content delivered through technology-enabled platforms that provide interactive People Assurance solutions to operations in the food industry. Alchemy's cloud-based software services help clients drive safety, productivity, operational excellence and customer service by monitoring skills gaps within their frontline operations and offering targeted interactive learning solutions.

 

Alchemy's industry-leading content and unique technology platforms are fully scalable within the food industry where Alchemy has 1,100+ clients. Alchemy's solutions are highly relevant across all industries with a large deskless frontline workforce and Intertek will leverage its scale to offer Alchemy's People Assurance solutions to its global client base across multiple business lines and industries outside food.

 

Founded in 2003 and headquartered in Austin, Texas, Alchemy employs approximately 270 people at four locations across the U.S. and Canada. Alchemy is majority owned by the private equity firm The Riverside Company. Alchemy will be acquired for a cash consideration of US$480m on a cash-free and debt-free basis.

 

Transaction highlights:

· Acquisition of an industry-leader, offering technology-enabled People Assurance SaaS (Software-as-a-Solution) that expands Intertek's global Assurance offering with bespoke People Assurance services

 

· Exposure to the highly attractive food industry where demand for quality assurance solutions is constantly growing, driven by increasing regulation and end-customer expectations

 

· Attractive subscription-based revenue model and the majority of Alchemy's customer contracts are 3-year contracts and Alchemy has a track record of high client retention rates

 

· Industry-leading People Assurance platform with broad-based learning content and strong technology platforms that are fully scalable

 

· Strong commercial synergies with Intertek's existing presence in the food supply chain globally as well as across Intertek's business lines in over 100 countries

 

· Alchemy's management team will remain with the business

 

Financial highlights: 

· Alchemy has a strong growth track record and operates a highly attractive business model: high growth, high margin, strong cash-conversion, capital-light and scalable

 

· Alchemy expects to record Billings of US$66m, adjusted Billings EBITDA of US$22m (33.0% margin) for the 12 months ending on 31 December 2018

 

· Annualised organic Billings growth of c.17% between 2016-2018e

 

· Intertek will finance the acquisition using available debt facilities and cash

 

· Intertek expects the acquisition to deliver attractive returns to shareholders and to be EPS accretive on a Billings basis in the first full year after acquisition

 

· 5 Year Guidance:

- 20% growth p.a. in billings/revenues going forward

- >30% IFRS EBITDA margin by year 5

- >25% IFRS EBIT margin by year 5

- Strong cash conversion; negative working capital

- ROIC > Group WACC by year 5

 

· The transaction is subject to customary closing conditions and is expected to be completed in Q3 2018

 

· Due to its subscription-based revenue model, which provides good revenue visibility, Alchemy manages its business on a billings basis. In its 2018 annual report, Intertek will report Alchemy's results in accordance with IFRS and noting that IFRS fair value purchase accounting requires us to revalue Alchemy's acquired deferred revenue balance

 

André Lacroix, Chief Executive Officer of Intertek, commented: 

 

"Intertek Total Quality Assurance (TQA) provides a superior service to our clients through our end-to-end systemic Assurance, Testing, Inspection and Certification (ATIC) solutions. With the acquisition of Alchemy, we are continuing to strengthen our TQA value proposition with the expansion of our Assurance business into People Assurance, helping to provide our clients with a higher level of quality assurance and with greater peace of mind.

 

Intertek's growth in Assurance services has predominantly been focussed on assuring the quality of clients' systems and operating procedures. Alchemy provides us with the opportunity to expand and broaden our Assurance offering towards the assurance of employee skills across our clients' organisations.

 

As corporations around the world increase their focus on quality, safety, productivity and compliance, closing skills-gaps to deliver only the highest customer service standards has become mission critical for clients. Alchemy's unique tailored learning software helps to close the loop, identifying and plugging these gaps quickly and efficiently.

 

Alchemy is a high-quality business with scalable solutions that can be rolled out across many different industries and geographies. This will further accelerate the growth momentum of our capital light and high margin Assurance Business.

 

We are delighted to welcome Alchemy and its strong management team to Intertek."

 

 

- ENDS -

 

Video

A video describing how we are continuing to strengthen and differentiate our TQA value proposition with the expansion of our global Assurance business into People Assurance can be viewed at http://www.intertek.com/investors/

Webcast

A live webcast for analysts and investors will be held today at 7.45am UK time; +44 (0) 20 3003 2666 (Link to webcast). Details can also be found at http://www.intertek.com/investors/ together with a pdf copy of this report. A recording of the audiocast will be available later in the day.

 

Contacts

For further information please contact:

Denis Moreau, Investor RelationsTelephone: +44 (0) 20 7396 3415 investor@intertek.com

Jonathon Brill, FTI ConsultingTelephone: +44 (0) 20 3727 1000 intertek@fticonsulting.com

 

About Intertek

Total Quality. Assured.

Intertek is a leading Total Quality Assurance provider to industries worldwide.

Our network of more than 1,000 laboratories and offices and over 42,000 people in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for our customers' operations and supply chains.

Intertek Total Quality Assurance expertise, delivered consistently, with precision, pace and passion, enabling our customers to power ahead safely.

intertek.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQEADPAEFAPEAF
Date   Source Headline
3rd Oct 20167:00 amRNSAcquisition
1st Sep 20161:00 pmRNSTotal Voting Rights
1st Aug 20161:00 pmRNSTotal Voting Rights
1st Aug 20167:00 amRNSHalf-year Report
1st Jul 20161:00 pmRNSTotal Voting Rights
1st Jun 20161:00 pmRNSTotal Voting Rights
26th May 20161:00 pmRNSDirector/PDMR Shareholding
25th May 20161:01 pmRNSDirectorate Change
25th May 20161:00 pmRNSResult of AGM
25th May 20167:01 amRNSDirectorate Change
25th May 20167:00 amRNSTrading Statement
23rd May 20161:00 pmRNSBlock listing Interim Review
3rd May 20161:00 pmRNSTotal Voting Rights
25th Apr 20167:00 amRNSDirector/PDMR Shareholding
20th Apr 20161:00 pmRNSRemuneration Committee Appointment
6th Apr 20167:00 amRNSAnnual Financial Report
1st Apr 20161:00 pmRNSTotal Voting Rights
22nd Mar 20161:00 pmRNSDirector/PDMR Shareholding
15th Mar 20163:00 pmRNSHolding(s) in Company
9th Mar 20161:00 pmRNSDirector/PDMR Shareholding
8th Mar 201611:45 amRNSDeath of a Director
2nd Mar 20161:00 pmRNSHolding(s) in Company
2nd Mar 201610:15 amRNS2016 Strategy Update
2nd Mar 20167:00 amRNSFinal Results
1st Mar 20161:00 pmRNSTotal Voting Rights
24th Feb 20161:01 pmRNSDirectorate Change
24th Feb 20161:00 pmRNSDirector/PDMR Shareholding
1st Feb 20161:00 pmRNSTotal Voting Rights
4th Jan 20161:00 pmRNSTotal Voting Rights
22nd Dec 20153:00 pmRNSNotice of Adoption of FRS 101
18th Dec 20157:00 amRNSNon Regulatory- Acquisition
1st Dec 20153:00 pmRNSTotal Voting Rights
1st Dec 20153:00 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSTrading Statement
23rd Nov 20159:00 amRNSBlocklisting Interim Review
2nd Nov 20151:00 pmRNSTotal Voting Rights
29th Oct 20157:00 amRNSDirector/PDMR Shareholding
26th Oct 20157:00 amRNSNon Regulatory- Acquisition
22nd Oct 20151:00 pmRNSHolding(s) in Company
14th Oct 20157:00 amRNSAcquisition
1st Oct 20151:00 pmRNSTotal Voting Rights
23rd Sep 20153:00 pmRNSDirector/PDMR Shareholding
14th Sep 20157:00 amRNSNon Regulatory- Acquisition
2nd Sep 20151:00 pmRNSHolding(s) in Company
1st Sep 20151:00 pmRNSTotal Voting Rights
3rd Aug 20151:00 pmRNSTotal Voting Rights
3rd Aug 20157:00 amRNSHalf Yearly Report
27th Jul 20153:00 pmRNSHolding(s) in Company
1st Jul 20151:00 pmRNSTotal Voting Rights
23rd Jun 20157:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.